Vaccine increases disease-free survival for follicular lymphoma patients
Tuesday, May 31, 2011 - 15:31
in Health & Medicine
A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University of Texas MD Anderson Cancer Center reported today in the online version of Journal of Clinical Oncology.